Issue link: https://www.e-digitaleditions.com/i/1233462
8 April 2020 Tablets & Capsules markets Pharma continuous manufacturing to grow 10 percent through 2026 DUBLIN, Ireland—The global pharmaceutical continuous manu- facturing market is forecast to grow at a compound annual rate of 10.2 percent, reaching $855 million by 2026, according to a report by Research and Markets. The benefits of continuous pharmaceutical man- ufacturing systems, which include reduced fluctuations in production, improved yields, and lower operat- ing and equipment costs along with FDA initiatives promoting continu- ous pharma manufacturing will spur market growth. Key market play- ers identified by the report include Syntegon, Coperion, Lödige, Glatt, Hosokawa Micron, Korsch, L.B. Bohle, Munson Machinery, and Thermo Fisher Scientific. Vegetarian capsules to dominate softgel market SLOUGH, UK—The global soft- gel market is projected to reach $3.66 billion by 2028, representing a com- pound annual growth rate of 5.1 per- cent, according to a report by Trusted Business Insights. The vegetarian soft- gel segment accounts for the major- ity of the market and is expected to grow during the forecast period. Key companies in this market include Thermo Fisher Scientific, Catalent, Lonza, Captek Softgel International, Sirio Pharma, Fuji Capsule, Weihai Baihe Biology Technological, Aenova, Sof t G el Technologies, Catalent Pharma Solutions, Procaps, Strides Pharma, International Vitamin, China Shineway Pharma, and Guangdong Yichao Biological. Increasing R&D investment to drive European prebiotic market growth PUNE, India—The European prebiotics market is forecast to grow at a compound annual rate of 9.5 percent through 2026, according to a report by Graphical Research. Increasing investments in R&D for product innovations to promote a healthier lifestyle are expected to drive market growth. Within the market, the German prebiotic seg- ment is expected to reach $930 million by the end of the forecast period. The report identifies Car- gill, Abbott Laboratories, Beneo, a n d F r i e s l a n d C a m p i n a a s k e y market players. industry news Conferences postponed due to novel coronavirus Due to the global rise of COVID- 19, many industry events have can- celed, digitized, or rescheduled their conferences and events. Interpharm Berlin, the ACS National Meet- ing, DCAT Week, Excipient World, PharmChina, and the Drug Develop- ment Networking Summit have been canceled. The following spring con-